FindTrial
Sign In

.

. - .

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2015-000189-71-FR
Enrollment
Unknown
Registered
2015-06-03
Start date
2015-03-27
Completion date
Unknown
Last updated
2016-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

. MedDRA version: 18.0 Level: LLT Classification code 10018061 Term: General anesthesia System Organ Class: 100000004865

Interventions

Product Name: Propofol Pharmaceutical Form: Solution for injection INN or Proposed INN: PROPOFOL LIPURO 2 % (20 mg/ml), émulsion injectable ou pour perfusion CAS Number: 570 528-3: Other descriptive n

Sponsors

CHU de Clermont-Ferrand
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: . Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20

Exclusion criteria

Exclusion criteria: .

Design outcomes

Primary

MeasureTime frame
Main Objective: .;Secondary Objective: .;Primary end point(s): .;Timepoint(s) of evaluation of this end point: .—

Secondary

MeasureTime frame
Secondary end point(s): .;Timepoint(s) of evaluation of this end point: .—

Countries

France

Contacts

Public ContactDélégation à la Recherche Clinique

CHU de Clermont-Ferrand

placarin@chu-clermontferrand.fr003304 73751195

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026